Timeline, a Lausanne, Switzerland-based consumer health biotech company, raised CHF 56M in Series D funding.
The round was led by BOLD (Business Opportunities for L’Oréal Development), L’Oréal Groupe’s strategic innovation venture capital fund.
The company intends to use the funds to expand the science, product categories, and markets across food, beauty and health sectors.
Led by Patrick Aebischer, Co-Founder and Chairman, Timeline is a health science company that has developed clinically proven, proprietary ingredient Mitopure®, which is incorporated inside its nutritional supplements and topical skin health products. Mitopure® is backed by over 15 years of research and is clinically proven to target a key cellular longevity pathway, by recycling and renewing the powerhouses inside cells, the mitochondria. Optimal mitochondrial function is essential for maintaining cellular energy which supports muscle strength, cognition, immune resilience, skin vitality and other important benefits, offering a comprehensive approach to promoting healthspan.
FinSMEs
17/01/2024